Quantinno Capital Management’s Aura Biosciences AURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.36M Buy
216,918
+86,262
+66% +$617K ﹤0.01% 2525
2026
Q2
$928K Buy
130,656
+39,581
+43% +$283K ﹤0.01% 2615
2026
Q1
$609K Buy
91,075
+54,694
+150% +$314K ﹤0.01% 2567
2025
Q4
$198K Sell
36,381
-8,260
-19% -$49K ﹤0.01% 3052
2025
Q3
$276K Buy
44,641
+22,769
+104% +$149K ﹤0.01% 2524
2025
Q2
$137K Buy
+21,872
New +$128K ﹤0.01% 2453

Other funds holding AURA

Quantinno Capital Management's AURA Position: Q3 2026 in Review

Quantinno Capital Management increased its Aura Biosciences (AURA) stake by 66% in Q3 2026, buying an estimated $617K and bringing the position to 216,918 shares worth $1.36M. The position accounts for ﹤0.01% of the portfolio, ranked #2525.

Quantinno Capital Management first reported a position in AURA in Q2 2025 and has held it in 6 quarters since. 98 funds tracked by Wall St. Rank hold AURA as of Q3 2026.

  • Quantinno Capital Management held 216,918 shares of Aura Biosciences worth $1.36M as of Q3 2026.
  • Quantinno Capital Management bought 86,262 Aura Biosciences shares in Q3 2026, an estimated $617K.
  • Aura Biosciences made up ﹤0.01% of Quantinno Capital Management's portfolio in Q3 2026, its #2525 holding.
  • Quantinno Capital Management first reported a position in Aura Biosciences in Q2 2025 and has held it in 6 quarters since.
  • 98 funds tracked by Wall St. Rank held Aura Biosciences as of Q3 2026.

Based on Quantinno Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.